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The intestinal commensal and opportunistic anaerobic pathogen Bacteroides fragilis 
has an essential requirement for both heme and free iron to support growth in ex-
traintestinal	infections.	In	the	absence	of	free	iron,	B. fragilis can utilize heme as the 
sole	 source	of	 iron.	However,	 the	mechanisms	 to	 remove	 iron	 from	heme	are	not	
completely	understood.	In	this	study,	we	show	that	the	inner	membrane	ferrous	iron	
transporter ∆feoAB mutant strain is no longer able to grow with heme as the sole 
source of iron. Genetic complementation with the feoAB gene operon completely 
restored growth. Our data indicate that iron is removed from heme in the periplasmic 
space,	and	the	released	iron	is	transported	by	the	FeoAB	system.	Interestingly,	when	
B. fragilis	utilizes	 iron	from	heme,	 it	 releases	heme-	derived	porphyrins	by	a	deche-
latase activity which is upregulated under low iron conditions. This is supported by 
the findings showing that formation of heme- derived porphyrins in the ∆feoAB mu-
tant and the parent strain increased 30- fold and fivefold (respectively) under low iron 






ties in an iron- dependent manner. These findings suggest that the mechanism to ex-
tract iron from heme in Bacteroides	 requires	a	group	of	proteins,	which	spans	 the	
periplasmic space to make iron available for cellular functions.
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1  | INTRODUC TION
Bacteroides fragilis is among the smallest components of the com-
mensal Bacteroides species found in the human gut ranging from 
<0.5%	 to	 4%	 of	 the	 total	 microflora	 (Holdeman,	 Good,	 &	Moore,	
1976;	 Kraal,	 Abubucker,	 Kota,	 Fischbach,	 &	 Mitreva,	 2014).	
However,	 B. fragilis emerges as the most prevalent anaerobic or-
ganism	 in	 human	 infections	 (Finegold	&	George,	 1989;	Mazuski	&	
Solomkin,	 2009;	McClean,	 Sheehan,	 &	Harding,	 1994;	 Park,	 Choi,	
Yong,	Lee,	&	Kim,	2009;	Smith,	Rocha,	&	Paster,	2006).	B. fragilis op-
portunistic infections occur as a consequence of a disruption in the 
integrity of the intestinal mucosa wall. Most of the bacteria leaked 
into the peritoneal cavity from the lumen is rapidly cleared by host 
defenses,	but	 the	anaerobe	B. fragilis and facultative bacteria such 
as Escherichia coli often escape clearance and are the predominant 
organisms	 found	 in	 resulting	 abscess	 infections.	 As	 consequence,	
the majority of intraabdominal infections are of polymicrobial na-
ture	 (Edmiston,	 Krepel,	 Seabrook,	 &	 Jochimsen,	 2002;	 Johnson,	
Baldessarre,	&	Levison,	1997).	Bacteroides fragilis	accounts	for	50%–
90%	of	all	anaerobes	 isolated	 from	 infections	of	which	peritonitis,	
intraabdominal	 abscesses,	 and	 bacteremia	 are	 the	 predominant	
morbidities.	In	the	event	of	a	rupture	in	the	abscess	wall,	B. fragilis 
may gain access to the bloodstream often leading to septic shock 
and systemic organ failure. Bacteroides fragilis is a deadly pathogen 
as	 it	 accounts	 for	 5%	of	 all	 positive	 blood	 cultures	with	mortality	
rates	of	16%–45%.	Despite	the	high	incidence	of	B. fragilis in intraab-
dominal	 infections,	 the	 full	 range	of	virulence	 factors	 that	allow	 it	




Eerola,	&	Meurman,	 1998;	Wilson	&	 Limaye,	 2004;	Yoshino	 et	al.,	
2012).
A	factor	 that	plays	an	 important	 role	 in	survival	of	B. fragilis in 
extraintestinal infection is its ability to acquire heme and inorganic 
iron	from	host	tissues	(Otto,	van	Dooren,	Dozois,	Luirink,	&	Oudega,	
2002;	Veeranagouda	et	al.,	2014).	Moreover,	when	B. fragilis is coin-
fected with E. coli strains producing hemoglobin protease during 
experimental	 polymicrobial	 infection,	 E. coli facilitates B. fragilis to 
utilize iron from heme to overcome host iron restriction mechanisms 
(Otto	et	al.,	2002).	Bacteroides fragilis as well as all other Bacteroides 
spp.	have	an	essential	requirement	for	heme	and	inorganic	iron,	and	
growth is stimulated by heme in a dose- dependent manner. In the 




ulation of Bacteroides by heme was shown to be due to activation 
of the fumarate reductase complex involved in the reduction of fu-




The heme- dependence of Bacteroides spp. is due to their in-
ability to synthesize precursors of the macrocycle tetrapyrrole 
ring	 protoporphyrin	 IX	 (PpIX).	 This	 is	 a	 distinctive	 characteris-
tic	 of	 host-	associated	 Bacteroidetes	 in	 the	 genera	 Bacteroides,	
Prevotella, and Porphyromonas which are unable to synthesize their 
own	PpIX	due	 to	 the	 lack	of	most	 genes	 required	 for	 the	 forma-
tion	 of	 the	 tetrapyrrole	 macrocycle,	 though	 they	 can	 synthesize	
heme	 in	 vitro	 if	 PpIX	 and	 inorganic	 iron	 are	 supplied	 (Olczak,	
Simpson,	Liu,	&	Genco,	2005;	Rocha	&	Smith,	2010).	Interestingly,	
this is a common characteristic of many bacterial species that 
colonize the lower intestinal tract of humans and other animals 
such as Bifidobacterium,	 Enterococcus,	 Lactococcus,	 Clostridium, 
and	euryarchaeota	 (Rocha	&	Smith,	2010).	 In	contrast,	 free	 living	
Bacteroidetes	such	as	Flavobacterium,	Cytophaga, and Salinibacter 








Another	 aspect	 of	 heme	 metabolism	 in	 B. fragilis that has re-
ceived little attention is its ability to dechelate divalent metal- 
porphyrins. Support for the presence of a dechelatase mechanism 
in B. fragilis is provided by several lines of evidence demonstrating 
that Bacteroides/Prevotella are versatile in the removal of nonfer-
rous divalent metal- bound porphyrins and side chain- modified 
porphyrins	 (such	 as	 Mn-	PpIX,	 Mg-	PpIX,	 Mn-	mesoporphyrin	
IX,	 Mg-	mesoporphyrin	 IX,	 Mn-	deuteroporphyrin	 IX,	 or	 Mg-	
deuteroporphyrin	 IX).	 After	 dechelation,	 ferrous	 iron	 is	 inserted	
into the porphyrin free metal pocket through an unidentified ferro-
chelatase	to	 form	heme,	mesoheme	or	deuteroheme,	 respectively.	
These activities seem to be relevant for cellular functions because 
heme itself or side chain- modified heme (mesoheme and deu-
teroheme) can be incorporated into the cytochrome b- type of the 
fumarate reductase complex and they are equally functional phys-
iologically	 (Caldwell	 et	al.,	 1965;	Fuller	&	Caldwell,	 1982;	Gardner,	
Fuller,	&	Caldwell,	1983;	McCall	&	Caldwell,	1977).
This resourceful tetrapyrrole utilization appears to be import-
ant for the metabolism of heme in extraintestinal infections as well 
as during intestinal tract colonization. The formation of heme- 
derived porphyrin in abscess pus is associated with the presence 
of anaerobic bacteria and the porphyrin pattern is remarkably 
similar	to	heme-	derived	porphyrin	 in	the	 intestinal	tract	 (Brazier,	
1990). The exogenous source of heme in abscesses may be pro-
vided by extravasated red blood cells and polymorphnuclear leu-
kocytes	(Brazier,	1990).	In	the	GI	tract,	the	unabsorbed	heme	that	
reaches the lower intestinal tract together with nonpathological 
sources of luminal heme (including physiological epithelial shed-
ding of cells and microbleeding) are converted by bacteria to a 
range	 of	 heme-	derived	 porphyrins	 (Beukeveld	 et	al.,	 1987;	 Rose	
et	al.,	1989;	Young,	Rose,	&	St	John,	1989;	Young,	Rose,	St	John,	




in feces of healthy human subjects depends entirely and exclu-
sively	 on	 the	 anaerobic	 bacterial	 flora	 (Beukeveld	 et	al.,	 1987;	
Rocha	&	Smith,	2010;	Rose	et	al.,	1989;	Young	et	al.,	1989,	1990).	
The aerobic and facultative anaerobic microbiota component of 
the intestinal tract plays no or a negligible role in the production 
of	 heme-	derived	 porphyrins	 in	 the	 gut	 (Beukeveld	 et	al.,	 1987).	
However,	there	is	a	paucity	of	information	on	the	mechanisms	of	
heme- iron assimilation and its contribution to the formation of 
heme- derived porphyrins in B. fragilis.
Though progress has been made to establish that heme is a 
major source of iron for Bacteroides	 both	 in	 vitro	 and	 in	 vivo,	 the	
mechanisms involved in heme- iron acquisition have not been fully 
characterized.	 In	 addition,	 there	 is	 a	 paucity	 of	 information	 re-
garding the identification of the lower intestinal anaerobic bacte-
ria species involved in heme dechelation and porphyrin side- chain 
modifications. In this study we show that when B. fragilis is grown 
on	heme	as	the	sole	source	of	iron,	the	ability	to	remove	iron	from	
heme	releasing	free	PpIX	is	regulated	by	iron	availability.	We	provide	
evidence that iron is removed from heme extracytoplasmically and 
assimilation of iron released from heme to stimulate bacterial growth 
is dependent on the presence of the inner- membrane ferrous iron 
transporter	system,	FeoAB.	Moreover,	this	study	shows	that	BtuS,	a	
member	of	the	CobN-	like	family	of	proteins	(Rodionov,	Vitreschak,	
Mironov,	 &	 Gelfand,	 2003),	 is	 involved	 in	 heme-	iron	 assimilation.	
Therefore,	this	study	demonstrates	that	heme	and	iron	metabolism	
in B. fragilis differs from the classical aerobic and facultative anaero-
bic bacterial systems.
TABLE  1 Bacteroides strains and plasmids used in this study
Relevant genotype References
Strains
B. fragilis 638R clinical	isolate,	RifR Privitera,	Dublanchet,	
&	Sebald	(1979)
B. fragilis	BER-	2 638R ∆furA::cfxA,	RifR CfxR Robertson et al. (2006)
B. fragilis	BER-	51 638R ∆feoAB::tetQ,	RifR TetR Veeranagouda et al. 
(2014)
B. fragilis	BER-	53 638R ∆feoAB::tetQ, ∆furA::cfxA,	RifR TetR CfxR This study
B. fragilis	BER-	125 638R ∆feoAB::tetQ,	feoAB+ TetR ErmR Veeranagouda et al. 
(2014)
B. fragilis	BER-	107 638R btuS1::pFD::516	RifR ErmR This study
B. fragilis	BER-	109 638R btuS2::pFD516	RifR ErmR This study
B. fragilis	BER-	111 638R btuS1::pFD516	btuS2::pYT102 RifR ErmR TetR This study
B. fragilis	BER-	114 BER-	111	pER-	179	RifR ErmR TetR CfxR This study
B. fragilis	BER-	115 BER-	111	pER-	180	RifR ErmR TetR CfxR This study
Plasmids
pYT102 Bacteroides suicide vector. (CmR),	TetR Baughn	&	Malamy	
(2002)
pFD340 Bacteroides	expression	shuttle	vector.	(AmpR),	ErmR Smith et al. (1992)
pFD516 Bacteroides suicide vector. (SpR),	ErmR Smith	et	al.	(1995)
pER-	167 A	528	nt	internal	N-	terminus	DNA	fragment	of	butS2 gene was cloned into the 
suicide	vector	pFD516
This study
pER- 168 An	approximately	694	nt	internal	N-	terminus	DNA	fragment	of	butS1 gene was 
cloned	into	the	suicide	vector	pFD516
This study
pER-	173 An	approximately	1,200	nt	internal	N-	terminus	DNA	fragment	of	butS1 gene 













Note. ErmR: erythromycin resistance; CfxR: cefoxitine resistance; RifR: rifamycin resistance; TetR: tetracycline resistance; CmR: chloramphenicol resist-
ance.	AmpR: ampicillin resistance; SpR:	spectinomycin	resistance.	Parenthesis	indicate	antibiotic	resistance	in	Escherichia coli.
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2  | MATERIAL S AND METHODS
2.1 | Bacterial strains and growth conditions
Bacteroides fragilis strains used in this study are shown in Table 1. 
Strains were routinely grown anaerobically in brain heart infusion 
medium	 (BHIS)	 containing	 l-	cysteine	 (1	g/L)	 and	 supplemented	




sible to define completely the modified forms of heme (strictly fer-
rous iron- protoporphyrin IX) macrocycle due to the variation in 
the	iron	valence	and	the	salts	formed	(see	Smith,	1990	for	review).	
In	addition,	heme	in	an	aqueous	solution	for	an	extended	time	can	
lead to formation of oxo- μ-	dimers	of	heme	(Smith,	1990).	Thus,	we	
hereafter	use	 the	 term	heme	 to	 refer	 to	an	 iron–protoporphyrin	
IX complex without specifically referring to its structural form or 
valence. Twenty μg/ml	rifamycin,	100	μg	gentamicin/ml,	5	μg tet-
racycline/ml,	and	10	μg erythromycin/ml were added to the media 
when required. Media were supplemented with the ferrous iron 
chelator	 bathophenanthroline	 disulfonic	 acid	 (BPS),	 which	 does	
not	enter	the	cell,	to	obtain	iron-	limiting	conditions	as	previously	
described	 (Rocha	&	Krykunivsky,	2017).	Addition	of	 ferrous	 iron	
sulfate or ammonium ferrous iron sulfate was used to obtain iron- 




2.2 | Construction of ∆feoAB ∆furA double- mutant
To construct a ∆feoAB ∆furA	 double	 mutant	 strain,	 the	 plasmid	




2004).	 Transconjugants	 were	 selected	 on	 BHIS	 plates	 containing	
20 μg	 rifamycin/ml,	 100	μg	 gentamicin/ml,	 25	μg	 cefoxitin/ml,	 and	
5	μg tetracycline/ml. Determination of sensitivity to either tetracy-
cline or erythromycin was carried out to identify recombinants that 
were	tetracycline	resistant	and	erythromycin	sensitive.	PCR	ampli-
fication analysis was used to confirm the double- crossover genetic 
allele exchange of pER- 66 into the B. fragilis	BER-	2	chromosome.	The	
new	transconjugant	BER-	53	containing	the	∆furA::cfxA ∆feoAB::tetQ 
genotype was selected for further studies.
2.3 | Construction of btuS1 and btuS2 
insertional mutants
A	 528	 nt	 fragment	 was	 amplified	 from	 the	 N-	terminus	 re-
gion of B. fragilis	 638R_2505	 (btuS1) gene using primers 
GAGGCGGATCCTGCCGCATCG,	 and	 CGAATGAGCTCCAAGTCTT 
CC containing modified nucleotides (bold font) and restriction 
sites	 (underlined)	 for	 BamHI	 and	 SstI,	 respectively.	 The	 amplified	
fragment	was	cloned	 into	 the	BamHI/SstI	 sites	of	 the	suicide	vec-
tor	 pFD516	 (Smith,	 Rollins,	 &	 Parker,	 1995).	 The	 new	 construct	
pER-	167	was	mobilized	 from	E. coli	DH10B	 into	B. fragilis 638R by 
aerobic triparental filter mating protocols as mentioned above. The 
transconjugants	were	selected	on	BHIS	agar	plates	containing	20	μg 
rifampicin/ml,	 100	μg	 gentamicin/ml,	 and	 10	μg erythromycin/ml. 
The B. fragilis btuS1::pFD516	 insertion	mutant,	 strain	BER-	107	was	
subjected	to	PCR	analysis	to	confirm	the	single	cross-	over	disruption	
of the target gene.
A	 694	 nt	 fragment	 was	 amplified	 from	 the	 N-	terminus	 re-
gion of B. fragilis	 638R_2718	 (btuS2) gene using primers 
GTTGTGTGGATCCGGCAATACTCG,	 and	 CGGACGAGCTCCATGA 
AACGG	containing	modified	nucleotides	(bold	font)	and	restriction	
sites	 (underlined)	 for	 BamHI	 and	 SstI,	 respectively.	 The	 amplified	
fragment	was	cloned	into	the	BamHI/SstI	sites	of	the	suicide	vector	
pFD516	and	the	new	construct	pER-	168	was	mobilized	from	E. coli 
DH10B	into	B. fragilis 638R by aerobic triparental filter as above. The 
transconjugants	were	selected	on	BHIS	agar	plates	containing	20	μg 
rifampicin/ml,	 100	μg	 gentamicin/ml,	 and	 10	μg erythromycin/ml. 
The B. fragilis btuS2::pFD516	 insertion	mutant,	 strain	BER-	109	was	
subjected	to	PCR	analysis	to	confirm	the	single	cross-	over	disruption	
of the target gene.
2.4 | Construction of btuS1 btuS2 double 
insertional mutant
A	 1,174	 nt	 fragment	 was	 amplified	 from	 the	 N-	terminus	 re-
gion of B. fragilis	 638R_2718	 (btuS2) gene using primers 





pER-	173	was	mobilized	 from	E. coli	DH10B	 into	BER-	107	strain	by	
aerobic triparental filter mating protocols as described above. The 
transconjugants	were	selected	on	BHIS	agar	plates	containing	20	μg 
rifampicin/ml,	 100	μg	 gentamicin/ml,	 10	μg erythromycin/ml and 
5	μg tetracycline/ml. The B. fragilis btuS1::pFD516	 btuS2::pYT102 
double	insertion	mutant,	strain	BER-	111	was	subjected	to	PCR	anal-




stream	 from	 the	 stop	 codon	 was	 PCR	 amplified	 using	 primers	
GGAGTTGGATCCGGAGTGAG	 and	 CAACCAGGATCCCCATCGCG,	
modified to include restriction sites as described above. This frag-
ment	 was	 then	 cloned	 into	 the	 BamHI	 site	 of	 pER-	178	 (Rocha	 &	
Krykunivsky,	2017).	Expression	of	 the	btuS1 gene is driven by the 
constitutive	 IS4351	 promoter	 from	 the	 original	 expression	 vector	
pFD340	 (Table	1,	 Smith,	 Rogers,	 &	 McKee,	 1992).	 The	 new	 con-
struct,	pER-	179	was	conjugated	into	BER-	111	by	triparental	mating	
to	obtain	BER-	114.
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For	 genetic	 complementation	 of	 BER-	111	 strain	 with	 btuS2 
gene,	a	4,490	nt	promoterless	DNA	fragment	of	the	BF638R_2718	
gene	 locus	 containing	 50	 nt	 upstream	 the	 ATG	 codon	 and	 94	 nt	
downstream	from	the	stop	codon	was	PCR	amplified	using	primers	
GATATCTCGGATCCTCCGGC	 and	 GTGGTTAGGATCCCGACTGC,	
modified to include restriction sites as described above. This frag-
ment	 was	 then	 cloned	 into	 the	 BamHI	 site	 of	 pER-	180	 (Rocha	 &	
Krykunivsky,	2017).	Expression	of	 the	btuS2 gene is driven by the 
constitutive	 IS4351	 promoter	 from	 the	 original	 expression	 vec-
tor	pFD340	 (Table	1,	 Smith	et	al.,	 1992).	 The	new	construct,	 pER-	
179	was	 conjugated	 into	 BER-	111	 by	 triparental	mating	 to	 obtain	
BER-	115.
2.5 | Determination of total heme and total 
porphyrin in whole cell dry extract
We used a modified spectrophotometric method described by 
Kufner,	 Schelegel,	 and	 Jager	 (2005)	 to	 extract	 and	 quantify	
total	 porphyrin	 and	 heme	 in	 dried	 bacterial	 pellets.	 Bacteria	
were	 grown	 on	 BHIS	 plates	 containing	 100	μg/ml heme and 
supplemented with either 100 μM ferrous ammonium sulfate 
or	 500	μM	 BPS	 for	 48–72	hr.	 Bacteria	 were	 washed	 from	 the	
plate	 surface	 with	 145	mM	 NaCl	 and	 centrifuged	 at	 12,000g 
for	10	mins	at	4°C.	The	pellets	were	washed	once	with	145	mM	
NaCl	 and	 transferred	 to	 a	 preweighed	 12	ml	 Falcon	 round-	
bottom	 tubes	 and	 centrifuged	 at	 12,000g	 for	 10	mins	 at	 4°C.	
The cell pellets were lysed by the addition of 200 μl chloroform 
and	 dried	 at	 65°C.	 To	 the	 dried	 pellets,	 550	μl releasing solu-
tion	 [hydroxyquinone	 10	g/L	 in	 formic	 acid/water	 75:25	 v/v]	
was	added,	vortexed	and	incubated	overnight	at	4°C.	Then	2	ml	
diethyl	ether	was	added,	and	samples	were	vortexed	and	left	at	
4°C	 for	1–2	hr	with	 frequent	 vortexing.	The	 suspensions	were	





of	 diisopropyl	 ether	 and	 0.5	ml	 ammonium	 formate	 solution	
(500	g/L)	was	added.	The	mixtures	were	vortexed	continuously	
for a few minutes and centrifuged. The lower buffer layer was 
discarded.	To	the	ether	upper	 layer,	1	ml	of	2.5	mol/L	HCl	was	
added and samples were vortexed continuously for a few min-
utes.	After	centrifugation,	the	upper	ether	layer	was	discarded.	
The lower acid layers were used to measure porphyrin concen-
tration.	The	light	protective	solution	(hydroxyquinone	20	mg/L	
in	2.5	mol/L	HCl)	was	prepare	before	use	and	used	as	measuring	
and blank solution in the determination of porphyrin content 
in the lower acid layer. Total protoporphyrin IX was calculated 





2.6 | Reverse phase HPLC analysis of 
porphyrin extract
Acid	extract	fractions	obtained	as	described	above	were	filtered	in	
a 0.2 μm nylon filter membrane before injecting samples with an 





pore	 size	 5	μm	particles)	 (Eprogen	 Inc.,	Darien,	 IL).	 To	 detect	 por-
phyrins the spectrofluorometer was set up with the following condi-
tions:	excitation	408	nm	(15	nm	bandwidths)	and	emission	620	nm	








and a run for 13 min before injection of the new sample according to 
Beukeveld	et	al.	(1987).	The	liquid	flow	rate	was	1.4	ml/min.	The	por-




UT.	Deuteroporphyrin	 IX	 dihydrochloride,	mesoporphyrin	 IX	 dihy-
drochloride,	 and	 pemptoporphyrin	 were	 purchased	 from	 Frontier	
Scientific.	 Protoporphyrin	 IX	 disodium	 salt	 was	 purchased	 from	
Sigma-	Aldrich	Co.,	 St.	 Louis,	MO.	The	 standard	markers	were	dis-
solved	in	2.7	mol/L	HCl	to	obtain	2	nmol/ml	solutions.
2.7 | Determination of the forward and reverse 
chelatase activity in whole cell crude extracts
Bacteria	were	grown	on	100	ml	BHIS	broth	containing	10	μg heme/
ml with 100 μM	ammonium	ferrous	sulfate	or	500	μM	BPS.	Bacteria	
were	grown	for	24–48	hr	on	iron-	replete	media.	For	growth	in	iron-	
limiting	conditions,	the	cultures	were	incubated	for	72–96	hr.	BHIS	




7.4]	 and	 centrifuged	 as	 above.	 The	 pellets	 were	 frozen	 at	 −70°C	
and	 submitted	 to	 the	 Iron	and	Heme	Core	 facility,	Department	of	
Internal	 Medicine,	 Division	 of	 Hematology,	 University	 of	 Utah	
Health	Sciences,	Salt	Lake	City,	UT,	to	assay	for	ferrochelatase	and	
dechelatase specific activities in bacterial crude extracts. The fer-
rochelatase assay described on the Iron and Heme core website 
(http://cihd.cores.utah.edu/ironheme/#1465838003097-f4fffc70-
f824)	is	a	modification	of	the	method	described	by	Rossi,	Costin,	&	
Garcia- Webb (1988). The dechelatase (reverse chelatase) assay was 
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adapted	from	the	methods	described	by	Chau,	Ishigaki,	Kataoka,	&	
Taketani	 (2010)	 and	 Taketani	 et	al.	 (2007).	 Briefly,	 approximately	
1	mg	total	protein	in	50	μl of bacterial crude extract was mixed with 
50	μL	of	 assay	 reagent	 containing	200	μM	hemin-	imidazole,	4	mM	
ascorbic	acid	 in	10	mM	potassium	phosphate	buffer	pH	5.5	under	
argon	 atmosphere.	 The	 enzyme	 assay	 was	 incubated	 at	 45°C	 for	
30	min.	After	 the	 addition	 of	 400	μL	50%	v/v	 acetone	 in	 ethanol,	
the	 samples	 were	 spun	 at	 13,500	g	 for	 10	min.	 The	 supernatant	
was	 analyzed	 by	UPLC	 (ultra-	performance	 liquid	 chromatography)	
for protoporphyrin IX fluorescence and quantification as described 
on the Iron and Heme core website (http://cihd.cores.utah.edu/
ironheme/#1467136333172-56f37fbb-2816).	 Bacterial	 crude	 ex-
tract samples were heated for 10 min in a boiling water bath and 
used as blank controls.
3  | RESULTS
3.1 | The role of feoAB in B. fragilis growth with 
heme as the sole source of iron
When B. fragilis strains were grown in DM supplemented with heme 
in	the	presence	of	the	ferrous	iron	chelator	BPS,	the	wild-	type	parent	
strain was able to grow in the presence of heme as the only source 
of	iron.	In	contrast,	the	growth	of	the	∆feoAB strain was abolished 
indicating	 that	 the	∆feoAB strain could no longer obtain essential 
iron	from	heme	(Figure	1a,b).	Partial	growth	of	the	∆feoAB occurred 
in	the	presence	of	5	μg and 10 μg heme/ml compared to maximum 
growth rate observed for the parent stain in media where residual 
iron	was	not	chelated	(Figure	1a,b).	When	PpIX	replaced	heme	as	the	
tetrapyrrole	macrocycle,	neither	the	parent	nor	the	∆feoAB mutant 
strains were able to grow in media that was iron- limited by the addi-
tion	of	BPS	(Figure	1c,d).	In	the	absence	of	BPS,	the	parent	but	not	
the ∆feoAB	 strain,	 grew	 in	 basal	medium	 containing	PpIX	without	
added	iron,	indicating	that	residual	iron	was	sufficient	to	support	the	
growth	 of	 the	 parent	 strain	 in	 the	 presence	 of	 PpIX	 (Figure	1c,d).	
The addition of 2 μM FeSO4 did not significantly stimulate the 
growth of the ∆feoAB	strain	in	the	presence	of	either	heme	or	PpIX,	







is	 present.	 Although	 B. fragilis does not possess a known HemH 
(PpfC)	homolog	(Rocha	&	Smith,	2010),	these	experiments	indicate	
that B. fragilis	 can	 synthesize	 essential	 heme	 if	 PpIX	 and	 iron	 are	
provided.	Moreover,	 these	 findings	suggest	 that	 in	 the	absence	of	
free	iron,	iron	is	removed	from	heme	in	the	periplasmic	space	since	
the	inner	membrane	transport	system	FeoAB	is	required	to	mobilize	
ferrous iron from the periplasmic space across the inner- membrane 
into the cytoplasm. It is unlikely that iron was removed from heme 
F IGURE  1 Growth of Bacteroides fragilis 638R (WT) and ∆feoAB mutant strains in defined medium containing heme (He) (a and b) or 
protoporphyrin	IX	(PpIX)	(c	and	d).	Ammonium	ferrous	sulfate	(Fe)	or	bathophenanthroline	disulfonic	acid	(BPS)	were	added	to	obtain	iron	
replete	and	iron-	limiting	conditions,	respectively.	The	concentrations	of	each	supplement	added	into	the	culture	media	are	described	in	the	
symbols legend below. (a and b) ♦	No	addition;	△	5	μg	He/ml;	□	10	μg He/ml; ▲	5	μg	He/ml	+	400	μM	BPS;	■ 10 μg	He/ml	+	400	μM	BPS;	○	
10 μg He/ml + 2 μM Fe; ♢ 10 μg He/ml + 100 μM Fe (only shown for ∆feoAB strain in b). (c and d) ♦	No	addition;	△	5	μg	PpIX/ml;	▲	5	μg	PpIX/
ml	+	400	μM	BPS;	●	5	μg	PpIX/ml	+	2	μM Fe; ♦	5	μg	PpIX/ml	+	100	μM Fe. Data presented are the average of two determinations in duplicate
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outside the cell before reaching the periplasm because extracellular 
free	iron	would	be	readily	available	for	chelation	by	BPS.
During the course of this investigation it was found that B. fragi-
lis	cultures	grown	in	the	presence	of	heme	and	BPS,	but	not	under	
iron-	replete	 conditions,	 produced	 porphyrin-	like	 pigment	 when	
exposed	 to	 longwave-	UV	 light	 (Supporting	 Information	Figure	S1).	
This	observation	was	further	analyzed	by	culturing	strains	on	BHIS	
plates containing high amount of heme at 100 μg/ml,	supplemented	
with either 100 μM	 ammonium	 ferrous	 sulfate,	 300	μM	 BPS,	 or	
1	mM	BPS.	After	7	days	of	 incubation,	the	plates	were	exposed	to	
longwave	 UV	 light	 at	 365	nm	 (Figure	2).	 There	 was	 no	 inhibition	
of	 growth	 or	 of	 fluorescent	 porphyrin	 production	 by	 the	 parent,	
∆furA,	 ∆feoAB,	 ∆feoAB ∆furA, and ∆feoAB/feoAB+ strains on iron- 
replete	 culture	 plates	 (Figure	2a).	 In	 contrast,	 under	 iron-	limiting	
conditions,	porphyrin	 fluorescence	was	clearly	 seen	 in	 the	parent,	
∆furA and ∆feoAB/feoAB+	strains	(Figure	2b,c).	However,	the	growth	
of the ∆feoAB and ∆feoAB ∆furA double- mutant strains were inhib-
ited	under	iron-	limiting	conditions,	confirming	that	the	formation	of	
heme- derived porphyrins was directly linked to heme as a source of 
iron. Genetic complementation of the ∆feoAB mutation with feoAB 




F IGURE  2 Growth of Bacteroides fragilis	strains	on	brain	heart	infusion	(BHIS)	media	containing	100	μg/ml	hemin.	Plates	were	
supplemented with (a) 100 μM FeSO4. (b) 300 μM	bathophenanthroline	disulfonic	acid	(BPS)	and	(c)	1	mM	BPS.	Bacteria	were	grown	in	an	
anaerobic	chamber	at	37°C	for	7	days.	Plates	were	illuminated	with	a	365	nm	UV-	long	wave	lamp	(UVP;	model	UVLS-	28,	Upland,	CA)	and	
pictures	were	taken	with	an	Olympus	Camedia	C-	4000	digital	camera.	WT:	B. fragilis 638R wild type. Strain designations are depicted on 
each panel
F IGURE  3 Total heme (a) and total porphyrin (b) determination in dried whole cell extracts of Bacteroides fragilis strains grown in brain 
heart	infusion	(BHIS)	media	containing	100	μg/ml hemin and supplemented with 100 μM	(NH4)2Fe(SO4)2	(Fe),	250	μM bathophenanthroline 
disulfonic	acid	(BPS)	or	1	mM	BPS.	Extraction	of	heme	(He)	and	protoporphyrins	(Pp)	from	dried	cells	was	performed	by	organic/acid	
aqueous phase separations as described in the materials and methods section. Growth of the ∆feoAB and ∆furA ∆feoAB strains was inhibited 
by	1	mM	BPS.	The	data	presented	are	the	mean	of	five	independent	experiments.	Standard	deviation	bars	represent	deviance	(±)	of	the	
mean
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3.2 | Determination of total heme and heme- 
derived porphyrins in whole cell extracts
When the 638R parent and ∆furA mutant strains were grown 
in medium containing 100 μg/ml heme and 100 μM ammonium 
ferrous	 sulfate,	 the	 total	 cellular	 heme	 amount	 was	 found	 to	
be	approximately	1.2	nmol/mg	and	2.2	nmol/mg	of	dry	weight,	
respectively.	 In	 the	 presence	 of	 1	mM	 BPS,	 the	 amount	 of	
heme	 decreased	 approximately	 fourfold,	 to	 0.3	nmol/mg	 and	
0.72	nmol/mg	 of	 dry	 weight,	 respectively	 (Figure	3a).	 In	 con-
trast,	the	amount	of	heme	in	the	∆feoAB and ∆feoAB ∆furA mu-
tant strains increased to 2.9 and 1.62 nmol/mg of dried weight in 
the	presence	of	250	μM	BPS	compared	to	0.48	and	0.61	nmol/
mg	of	 dried	weight	 under	 iron	 replete	 conditions,	 respectively.	
No	growth	of	 the	∆feoAB and ∆feoAB ∆furA strains occurred in 
media	 containing	 1	mM	BPS	 (Figure	3a,b).	 The	 amount	 of	 total	
porphyrins found in the parent and ∆furA strains was higher ap-
proximately	 fivefold	 and	 10-	fold	 respectively,	 in	 the	 presence	
of	 1	mM	 BPS	 (0.12	 and	 0.30	nmol/mg	 of	 dried	 weight)	 com-
pared to the amount under iron- replete conditions (0.026 and 
0.029 nmol/mg of dried weight) (Figure 3b). In the ∆feoAB	strain,	
there was approximately a 30- fold increase in the amount of por-
phyrins under iron restricted conditions (0.38 nmol/mg of dried 
weight) compared to iron- replete conditions (0.012 nmol/mg of 
dried	weight),	 respectively.	 In	 the	∆feoAB ∆furA	 strain,	porphy-
rins increased approximately sevenfold under iron- restricted 
conditions	 (0.153	nmol/mg	 of	 dried	 weight)	 compared	 to	 iron-	
replete conditions (0.02 nmol/mg of dried weight) (Figure 3b).
These findings clearly show that accumulation of heme- derived 
porphyrin occurs in the presence of heme when free iron is not avail-
able. They also demonstrate that B. fragilis is able to remove iron 
from heme releasing free- protoporphyrin in a Fur- independent man-
ner,	indicating	the	presence	of	a	yet	to	be	identified	iron-	regulated	
heme dechelatase mechanism.
3.3 | Iron inhibits the formation of the heme- 
derived porphyrins
To confirm that excess iron had an inhibitory effect on the pro-
duction	of	heme-	derived	porphyrin,	B. fragilis strains were spread 
on	BHIS	agar	supplemented	with	100	μg/ml	heme	and	1	mM	BPS.	
Then a filter paper disk was placed on top of the agar and 10 μl 
0.5	M	ammonium	ferrous	sulfate	solution	was	added	on	top	of	the	
filter	paper	(Figure	4).	Sterile	water	was	used	as	control.	The	parent	
and	∆furA mutant strains were able to grow on the entire plates 
containing heme as the only source of exogenous iron. Formation 
of fluorescent heme- derived porphyrin was observed further away 
from the iron diffusion zone around the disk filter impregnated 
with	ammonium	ferrous	sulfate.	 In	contrast,	no	fluorescence	was	
observed	 around	 the	 disk	 diffusion	 area,	 indicating	 that	 excess	
of inorganic iron was able to inhibit formation of heme- derived 
porphyrin	 (Figure	4,	 top	 panels).	 The	 ∆feoAB	 and	 ∆feoAB	 ∆furA 
double mutant strains only grew around the disk filter and not fur-
ther	away	from	the	 iron	diffusion	zone	(Figure	4,	bottom	panels).	
Moreover,	no	fluorescence	was	observed	for	the	feoAB	or	∆feoAB 
∆furA strains except on the edge of the lawn where iron was likely 
F IGURE  4 Growth of 
Bacteroides fragilis strains on brain heart 
infusion	(BHIS)	media	containing	100	μg/
ml hemin plus 1 mM bathophenanthroline 
disulfonic	acid	(BPS).	Bacteria	were	spread	
on the surface of the plates and sterile 
disk filter papers were placed on top of 
the agar. 10 μl	of	sterile	0.5	M	ammonium	
ferrous sulfate in double- deionized H2O or 
10 μl sterile double- deionized H2O were 
added on respective disk filter papers 
as	indicated	in	the	panels.	Bacteria	were	




were taken with an Olympus Camedia C- 
4000	digital	camera.	WT:	B. fragilis 638R 
wild type. Strain designations are depicted 
for	each	panel.	Bottom	panel	insets	depict	
the bacterial growth edge area around the 
disk diffusion zone
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F IGURE   5 Chromatograms of free porphyrin acids analyzed by reverse- phase high- performance liquid chromatography. Total 
porphyrins were extracted in acid phase from dried whole cells of Bacteroides fragilis	strains	grown	in	brain	heart	infusion	(BHIS)	media	
containing 100 μg/ml heme (He) and supplemented with 100 μM ammonium ferrous sulfate (Fe) or 1 mM bathophenanthroline disulfonic 
acid	(BPS).	For	growth	of	the	∆feoAB	strain	under	iron-	limiting	conditions,	250	μM	BPS	was	used.	The	inset	graph	is	an	enlargement	
showing	a	minor	peak	with	retention	time	equivalent	to	mesoporphyrin	IX.	The	procedures	for	porphyrin	acid	extracts,	gradient	









that formation of heme- derived porphyrin is iron regulated in a 
Fur- independent manner.
3.4 | Reverse- phase HPLC analysis of heme- derived 





inorganic iron restricted conditions were elevated approximately 
10–20-	fold	for	the	parent	and	∆feoAB strains compared to the peak 
intensity under iron replete conditions. Other minor peaks were 
also observed in the chromatogram which overlapped well with 
the retention time observed for a deuteroporphyrin IX standard. 
Interestingly,	a	peak	similar	to	the	retention	time	of	mesoporphyrin	
IX	was	also	observed	in	∆feoAB cultures grown under iron restricted 
conditions	(Figure	5	inset).	The	specific	organic	structure	and	chemi-
cal composition of these porphyrins was not further determined. 
Nonetheless,	these	findings	clearly	show	that	B. fragilis possesses a 
dechelatase mechanism which is regulated by inorganic iron avail-
ability,	and	we	also	show	that	removal	of	iron	from	heme	does	not	
break the tetrapyrrole macrocycle structure hence releasing free 
PpIX.	Moreover,	 these	 findings	 demonstrate	 that	B. fragilis is able 
to	modify	the	PpIX	side-	chain.	No	detectable	traces	of	porphyrins	
were found in uninoculated culture media (Supporting Information 
Figure S2).
3.5 | Genetic analysis of CobN- like chelatases in 
B. fragilis
A	 search	 in	 the	 genome	 of	 B. fragilis 638R strain revealed the 
presence	 of	 two	 putative	 operons	 (BF638R_2501-	2512	 and	
BF638R_2714-	2721)	containing	CobN-	like	chelatases	belonging	to	
the	BtuS	family;	BF638R_2504	(BtuS1)	and	BF638R_2718	(BtuS2),	
respectively	 (Supporting	 Information	 Figure	 S3).	 The	 BtuS	 family	
of	chelatases	have	been	proposed	as	a	third	type	of	CobN-	related	
protein,	distinct	from	the	B12-	regulated	cobalt	chelatase	CobN	in-
volved	 in	 the	 cobalamin	 synthesis,	 and	 the	 magnesium	 chelatase	
ChlH required for the bacteriochlorophyll biosynthesis (Rodionov 
et	al.,	 2003).	 The	 BtuS	 family	 of	 proteins	 (pfam02514)	 contains	 a	
domain	 common	 to	 the	CobN	protein	 and	 to	 the	magnesium	pro-
toporphyrin chelatase (https://www.ncbi.nlm.nih.gov/Structure/
cdd/cddsrv.cgi?uid=pfam02514).	Though	BtuS	is	predicted	to	be	in-
volved in the salvage of metalloporphyrins rather than cobalamine 
biosynthesis	 (Rodionov	et	al.,	2003),	 its	role	 in	anaerobic	heme	as-
similation and utilization in B. fragilis has not been investigated. The 
BF638R_2714-	2721	operon	contains	homologs	to	the	iron-	induced	
hmu locus for heme and hemoglobin utilization in Porphyromonas gin-
givalis	 (Lewis,	 Plata,	 Yu,	 Rosato,	&	Anaya,	 2006;	 Simpson,	Olczak,	
&	Genco,	2000)	suggesting	that	BtuS1	and	BtuS2	could	play	a	role	
in heme assimilation in Bacteroides.	A	phylogenetic	analysis	of	BtuS	
homologs from B. fragilis	with	other	CobN	and	CobN-	like	homologs	
from	bacteria	and	archaea	phyla	showed	that	BtuS1	and	BtuS2	are	
branched	 in	 two	 distinct	 groups	within	 the	 Bacteroidetes	 phylum	
(Supporting	 Information	Figure	S4).	Most	Bacteroides species con-
tain a single homolog of btuS with the exception of nearly all B. fra-
gilis strains which carry both the btuS1 and the btuS2 homologs. 
Interestingly,	homologs	of	btuS gene were found to be absent in the 
genomes of Bacteroides vulgatus	20-	15	and	40G2-	33	strains	(unpub-
lished data) which are unable to grow on heme alone as the source 
of	 iron	 (Rocha	 &	 Krykunivsky,	 2017).	 Moreover,	 transmembrane	
protein topology predictions using web- based servers TMMOD: 
Hidden Markov Model for transmembrane protein topology (http://
liao.cis.udel.edu/website/webscripts/frame.php?p=home)	 (Kahsay	
et	al.,	 2005)	 and	 membrane	 topology	 and	 signal	 peptide	 analysis	





removing iron from heme in the periplasmic space. This correlates 
nicely with the findings shown above demonstrating that the inner 
membrane	transporter	FeoAB	is	required	for	the	assimilation	of	iron	
released	from	heme	outside	of	the	cytoplasm.	Therefore,	btuS1 and 
btuS2 genes were chosen for further characterization.
3.6 | Role of the CobN- like proteins BtuS1 and  
BtuS2 during growth with heme as the sole 
source of iron
To	test	the	role	of	BtuS	proteins	in	the	utilization	of	heme-	iron,	bac-
teria	were	grown	in	DM	containing	5	μg/ml heme and supplemented 
with 100 μM	ammonium	ferrous	sulfate	or	500	μM	BPS.	In	the	pres-
ence	of	heme	and	inorganic	iron	replete	conditions,	no	growth	de-
fect was observed for the btuS1,	btuS2 or btuS1 btuS2 double mutant 
strains	 compared	 to	 the	 parent	 strain	 (Figure	6a).	 However,	when	
bacteria	were	grown	with	heme	alone	as	a	sole	source	of	 iron,	the	
btuS1 btuS2 double mutant showed a growth defect compared to 
the parent and single mutant strains (Figure 6b). The btuS1 single 
mutant did not show a significant growth defect while btuS2 mutant 
showed a partial decrease in growth rate compared to parent strain. 
Growth of complemented strains was restored in part compared to 
the parent strain. The lack of complete complementation in the mu-
tant strain may have been due to a polar mutation effect disrupting 
the expression of downstream genes which appear to be organized 
in	a	polycistronic	operon.	Moreover,	genetic	complementation	car-
ried out with single btuS1 or btuS2 genes in a multicopy plasmid may 
also	have	contributed	to	a	pleiotropic	effect.	Nonetheless,	 this	 in-
dicates	that	BtuS	proteins	are	involved	in	acquisition	of	heme-	iron.	
However,	to	our	surprise,	the	btuS1 btuS2 double mutant strain did 
not abolish the ability of B. fragilis to remove iron from heme releas-
ing	 free	 PpIX	 (Figure	5).	 In	 fact,	 the	 relative	 intensity	 of	 the	 PpIX	
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of	free	PpIX	in	the	btuS1 btuS2 double mutant indicates that the iron 
released from heme does not appear to be efficiently assimilated to 
support growth as addition of exogenous inorganic iron can restore 
the growth defect phenotype.
3.7 | BtuS modulates dechelatase and 
ferrochelatase activities in vitro
Though functional btuS1 and btuS2 genes are not required for B. fra-
gilis	 to	dechelate	heme,	 they	 are	 involved	 in	 the	 regulation	of	 the	
forward and reverse chelatase enzymatic activities measured in 
the cellular crude extracts. When B. fragilis was grown with heme 
under	 inorganic	 iron	 limited	conditions,	 the	reverse	chelatase	spe-
cific activity increased approximately eightfold in the btuS1 btuS2 
double	 mutant	 (225	pmol	mg−1 hr−1) compared to the specific ac-
tivity (28 pmol mg−1 hr−1) in the parent strain grown under iron 
restricted	 conditions	 (Figure	7a).	 In	 contrast,	 under	 iron	 replete	
conditions,	the	reverse	chelatase	specific	activity	in	the	parent	strain	
(8 pmol mg−1 hr−1) did not significantly differ from the btuS1 btuS2 
double	mutant	(5	pmol	mg−1 hr−1).
However,	when	bacteria	were	 grown	 in	 the	 presence	 of	 PpIX,	
the	 reverse	 chelatase	 activity	 increased	 approximately	 50-	fold	
in the btuS1 btuS2 double mutant (138 pmol mg−1 hr−1) compared 
to the parent strain (2.8 pmol mg−1 hr−1) under iron replete con-
ditions	 (Figure	7c).	 Under	 iron	 limitation,	 the	 reverse	 chelatase	
activity	 was	 elevated	 approximately	 3.5-	fold	 in	 the	 btuS1 btuS2 
double	mutant	(21.4	pmol	mg−1 hr−1) compared to the parent strain 
(6.1 pmol mg−1 hr−1)	 (Figure	7c).	 Moreover,	 the	 forward	 chelatase	
activity increased approximately threefold in the btuS1 btuS2 dou-
ble mutant (986 pmol mg−1 hr−1) compared to the parent strain 
(305	pmol	mg−1 hr−1)	 under	 iron	 replete	 conditions	 (Figure	7b).	 In	
contrast,	the	forward	chelatase	activity	did	not	change	significantly	
in	 the	 parent	 strain	 (194.9	pmol	mg−1 hr−1) compared to the btuS1 
btuS2	double	mutant	strain	(153.9	pmol	mg−1 hr−1) under iron limited 
conditions	(Figure	7b).
Overall these findings demonstrate that the ability to dechelate 
heme	 is	 upregulated	 by	 iron	 limitation	 and	 that	 BtuS1	 and	 BtuS2	
proteins	 seem	 to	 have	 a	 negative	 regulatory	 effect.	 However,	 in	
the	presence	of	PpIX,	the	negative	regulatory	effect	is	higher	under	
F IGURE  6 Growth of Bacteroides fragilis	strains	in	defined	medium	containing	5	μg heme/ml (He). Media was supplemented with 100 μM 
ammonium	ferrous	sulfate	(Fe)	(a)	or	400	μM	bathophenanthroline	disulfonic	acid	(BPS)	(b)	to	obtain	iron	replete	and	iron-	limiting	conditions	
respectively. ♦ B. fragilis	638R	wild	type;	□	BER-	107	(btuS1); ▲	BER-	109	(btuS2); ■	BER-	111	(btuS1 btuS2);	○	BER-	114	(btuS1 btuS2 btuS1+);  
●	BER-	115	(btuS1 btuS2 btuS2+).	The	growth	curves	for	BER-	114	and	BER-	1115	strains	are	only	shown	in	(b).	Data	presented	are	an	average	
of two determinations in duplicate
F IGURE  7 Ferrochelatase (FeCH) and reverse ferrochelatase activity assays in crude extracts of Bacteroides fragilis 638R (WT) and 
btuS1 btuS2	double-	mutant	strains.	Bacteria	were	grown	in	brain	heart	infusion	(BHIS)	medium	containing	10	μg heme/ml (He) or 10 μg 
protoporphyrin	IX	(PpIX)/ml.	Media	was	supplemented	with	100	μM	ammonium	ferrous	sulfate	(Fe)	or	500	μM bathophenanthroline 
disulfonic	acid	(BPS).	Bacteria	were	grown	anaerobically	at	37°C	for	24–48	hr	under	iron	replete	conditions	and	for	72–96	hr	under	iron-	
limiting conditions. Details of the forward ferrochelatase and reverse ferrochelatase reaction assay settings are described in the material and 
methods section
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iron replete conditions than under iron restricted conditions. This 
negative effect is also observed for the forward chelatase activity 
under	iron	replete	conditions	but	in	contrast	to	the	reverse	activity,	
the forward chelatase activity it is not regulated by iron restriction. 
Though the biochemical and genetic control mechanisms for the 
forward	and	reverse	chelatase	activities	remain	to	be	characterized,	
we	show	in	this	study	that	the	BtuS1	and	BtuS2	participate	 in	the	
negative regulation of the forward and reverse chelatase activities 
of the heme metabolism in B. fragilis.	In	many	bacteria,	heme	homeo-
stasis is controlled at the initial steps of the biosynthetic pathway 
by	 HemX,	 a	 transmembrane	 anchored	 protein	 that	 regulates	 the	
abundance	of	glutamyl-	tRNA	reductase,	GtrR	 (Choby	et	al.,	2018).	
In	other	bacteria	such	as	the	alpha-	proteobacteria,	control	of	heme	
biosynthesis occurs through the direct interaction of the Irr regula-
tor with the ferrochelatase to modulate gene expression under iron- 
limiting	conditions	(Small,	Puri,	&	O’Brian,	2009).
Therefore,	we	believe	that	the	mechanism	to	extract	 iron	from	
heme and make it available for cellular functions in Bacteroides 
requires	 a	 group	 of	 proteins	 acting	 together,	 possibly	 forming	 a	
complex,	which	spans	the	periplasmic	space.	The	BtuS1	and	BtuS2	




In	this	study,	we	show	that	the	ability	of	B. fragilis to remove iron from 
heme	 releasing	 free	 PpIX	 is	 dependent	 on	 an	 unidentified	 deche-
latase activity mechanism that is upregulated when bacteria are pre-
sent	in	an	iron-	limiting	environment.	Moreover,	we	demonstrate	that	
utilization of iron removed from heme requires the inner membrane 
ferrous	iron	transporter	system,	FeoAB,	 indicating	that	the	deche-
latase activity occurs in the periplasmic space. It is well documented 
that	members	of	the	Bacteroidetes	phylum	such	as	Porphyromonas 
and Prevotella	 are	 able	 to	 release	 iron	 and	 form	 free	 PpIX	 from	
heme	(Brazier,	1986;	Fyrestam,	Bjurshammar,	Paulsson,	Johannsen,	
&	Östman,	2015;	Fyrestam	et	al.,	2017;	Shah,	Bonnett,	Mateen,	&	
Williams,	 1979;	 Slots	 &	 Reynolds,	 1982;	 Smalley	 &	Olczak,	 2017;	
Soukos	et	al.,	2005).	The	removal	of	iron	from	heme	in	Prevotella mel-
aninogenica (formerly black- pigmented Bacteroides melaninogenicus) 
occurs	by	the	action	of	an	unidentified	demetallase,	which	was	el-
egantly	demonstrated	by	Shah	et	al.	(1979).	Other	studies	have	sug-
gested that the ability of P. gingivalis to remove iron from heme could 
be due to the reverse activity of its ferrochelatase HemH (Olczak 
et	al.,	2005).	 It	has	also	been	suggested	 that	 the	P. gingivalis outer 
membrane	 cobalt	 chelatase	 CbiK-	like	 protein	 IhtB	 may	 remove	
iron	 from	 heme	 extracellularly	 (Dashper	 et	al.,	 2000).	 However,	
the lack of ferrochelatase HemH in B. fragilis	(Rocha	&	Smith,	2010)	
and the findings that disruption of the cobalt chelatase ckiK gene 
(BF638R-	2502)	did	not	affect	utilization	of	heme-	iron	(unpublished	
data) indicate that the dechelatase mechanism in B. fragilis differs 
from the ones proposed for the related organism P. gingivalis. The 
disruption	 of	 the	 BF638R_2327	 gene,	 a	 homolog	 to	 yfeX belong-
ing	 to	 the	 DYP-	peroxidase	 family	 of	 proteins	 which	 is	 implicated	
in heme dechelation in E. coli	 (Létoffé,	Heuck,	Delepelaire,	 Lange,	
&	Wandersman,	2009)	did	not	affect	removal	of	iron	from	heme	in	
B. fragilis	(unpublished	data).	Moreover,	the	deferrochelatase/perox-
idase efeB in E. coli	(Létoffé	et	al.,	2009),	has	no	homolog	in	B. fragilis 
(data not shown). These findings suggest that Bacteroides spp. have 
developed a novel mechanism(s) to utilize heme- iron.
It seems that there is dual coordinated regulation of heme- iron 
utilization in B. fragilis.	Firstly,	the	FeoAB	transporter,	necessary	for	
the	utilization	of	ferrous	iron	released	from	heme,	is	regulated	by	iron	
F IGURE  8 Schematic	putative	model	of	the	involvement	of	the	ferrous	iron	transporter	FeoAB	and	the	CobN-	like	BtuS1	and	BtuS2	
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in	a	Fur-	dependent	manner	(Rocha	&	Krykunivsky,	2017).	Secondly,	
the	removal	of	 iron	from	heme	by	dechelatase	activity,	modulated	
by	BtuS1	 and	BtuS2	 proteins,	 is	 regulated	 by	 iron	 availability	 in	 a	
Fur- independent manner. The transport of ferrous iron in intestinal 
anaerobes is still poorly understood. In aerobic and facultative anaer-
obic bacteria the Feo system is generally composed of the small cy-
toplasmic	protein	FeoA	and	the	large	transmembrane	protein	FeoB.	
This stands in contrast to many upper and lower GI tract anaerobes 
such as Porphyromonas,	Bacteroides Eubacterium,	Ruminococcus, and 




served	 among	 the	 Bacteroidetes,	 and	 among	 the	 Firmicutes	 and	
Actinobacteria	phyla	of	intestinal	colonizers	(Rocha	&	Smith,	2010).	
As	 far	we	are	aware,	 fused	FeoAB	peptides	are	not	 found	 in	non-
gastrointestinal organisms suggesting its unique importance for the 
physiology	of	 intestinal	 anaerobic	bacteria	 (Rocha	&	Smith,	2010).	
We	have	previously	shown	that	the	lack	of	FeoAB	impaired	B. fragi-
lis to form abscesses in a mouse model of infection (Veeranagouda 
et	al.,	2014).	However,	in	light	of	this	study,	this	growth	deficiency	is	
likely to have been due to the ∆feoAB strain inability to acquire both 
heme- iron and inorganic iron from host tissues.
It	is	not	clear	how	BtuS1	and	BtuS2	affect	the	regulation	of	both	
the chelatase and dechelatase enzymatic activities as demonstrated 
in the in vitro assays using whole cell extracts. We assume that the 
effect	 of	 CobN-	like	BtuS	 family	 of	 proteins	 on	 the	 ferrochelatase	
and dechelatase activities may provide advantageous benefits for 
B. fragilis pathophysiology and commensal intestinal colonization. 
At	least	with	regard	to	the	dechelatase	activity,	it	appears	to	be	lo-
cated	 in	 the	 periplasmic	 space.	 At	 this	 point	 of	 investigation,	 it	 is	
unclear	how	BtuS1	and	BtuS2	interact	with	and	affect	dechelatase	
activity,	and	the	physiological	significance	of	their	regulatory	effect.	
However,	 the	 fact	 that	 the	 iron	 released	 from	 heme	 in	 the	 peri-
plasm seems to be less efficiently assimilated to support growth of 
the btuS1 btuS2	double-	mutant,	it	points	out	a	potential	role	for	the	
BtuS1	and	BtuS2	system	in	facilitating	its	utilization.	It	may	be	ener-
getically cost effective to remove iron from heme or modify the por-
phyrin side- chain in the periplasmic space rather than transporting 
porphyrins across cellular membranes for export. It is possible that 
this mechanism might facilitate rapid exchange of porphyrins and 
side	chain-	modified	porphyrins	among	intestinal	bacteria,	especially	
in view of the fact that B. fragilis can incorporate side chain- modified 
heme into cytochrome b-	type	(for	review	see	Rocha	&	Smith,	2010).
Recent studies have demonstrated that the oral pathogens 
P. gingivalis,	 Aggregatibacter actinomycetemcomitans,	 Prevotella in-
termedia,	 Prevotella nigrescens,	 and	 P. melaninogenica produce 
endogenous porphyrins when grown on media containing an-
imal	 blood	 (Fyrestam	 et	al.,	 2015;	 Soukos	 et	al.,	 2005).	 The	
Porphyromonas and Prevotella	 porphyrins	 were	 mostly	 PpIX,	 co-
proporphyrinogen	 I,	and	coproporphyrinogen	 III	 (Fyrestam	et	al.,	
2015,	2017;	Soukos	et	al.,	2005).	However,	no	side	chain-	modified	
porphyrin such as mesoporphyrin IX or deuteroporphyrin IX were 
reported	 to	 be	 formed	 by	 these	 oral	 bacteria	 (Fyrestam	 et	al.,	
2015,	 2017;	 Soukos	 et	al.,	 2005).	 Therefore,	 the	 presence	 of	
PpIX,	mesoporphyrin	IX	and	deuteroporphyrin	IX	found	in	B. fra-
gilis suggests that this organism contributes to the appearance of 
heme- derived porphyrins and side chain- modified porphyrins in 
extraintestinal infections as well as in the intestinal tract. This is 
in agreement with previous studies demonstrating that intestinal 
anaerobic bacteria are exclusively responsible for the conversion 
of	heme	to	PpIX	 lacking	 iron,	and	modifications	of	the	vinyl	side	
chains	of	heme	and	PpIX	 to	 their	 respective	deutero,	meso,	 and	
pempto	 side	 chain	 forms	 (Beukeveld	 et	al.,	 1987;	 Young	 et	al.,	
1989,	1990).	There	is	a	wide	range	of	variations	in	the	amount	and	
type	of	heme-	derived	porphyrins	among	individuals,	but	the	types	
of heme- derived porphyrins seem to be consistent within a given 
individual	(Young	et	al.,	1990).	Though	fecal	flora	metabolism	and	
redox potential may account for the differences in the amount and 
types	of	heme-	derived	porphyrins	(Young	et	al.,	1990),	we	demon-
strate in this study that intestinal iron limitations may also contrib-
ute to the fluctuations in the amount of heme- derived porphyrins 
formed by intestinal anaerobic bacteria.
Though heme has been shown to be inhibitory to many Gram- 
positive	 and	 Gram-	negative	 bacteria	 in	 vitro	 (Nitzan,	 Wexler,	 &	
Finegold,	1994),	dietary	heme	has	a	robust	effect	in	enhancing	the	
abundance	 of	 Bacteroidetes	 relative	 to	 the	 Firmicutes	 population	
in	mouse	 intestinal	 colonization	models	 (Ijssennagger	 et	al.,	 2012,	
2015).	 In	 addition	 to	 this	 effect	 on	 bacterial	 colonization,	 heme-	
induced hyperproliferation and hyperplasia in the mouse colon only 
occurs	 in	 the	 presence	 of	 the	 gut	 microbiota	 (Ijssennagger	 et	al.,	
2015).	The	 specific	bacterial	 species	 involved	 in	 such	mechanisms	
have	not	been	identified,	and	whether	there	is	a	link	between	bac-
terial action on modifications of heme structure and heme- derived 
porphyrins in enhancing or weakening heme mucosa toxicity remains 
to be determined. In this study we identify B. fragilis as being one of 
these bacteria able to act on and modify labile heme molecules in 
vitro.	 Because	 formation	 of	 heme-	derived	 porphyrin	 seems	 to	 be	
regulated	by	free	iron	availability,	we	think	that	heme-	derived	por-
phyrins might be relevant for B. fragilis pathophysiology in extraint-
estinal infections where iron is limited by the host. This assumption 
is based on the fact that protoporphyrin IX acts as a competitive 
inhibitor of the proinflammatory activity of labile heme in macro-
phages	 (Figueiredo	et	al.,	 2007;	Soares	&	Bozza,	2016).	Moreover,	
we speculate that by modifying or scavenging labile heme in the site 
of	 infection,	B. fragilis may alter the signaling effect of labile heme 
on	recruitment	of	neutrophil	and	oxidative	burst	 (Figueiredo	et	al.,	
2007;	 Soares	 &	 Bozza,	 2016).	 Further	 investigation	 on	 heme-	iron	
utilization systems and regulation will advance our understanding 
on the role heme plays in Bacteroides pathophysiology.
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